CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing incidences of zoonotic diseases
4.1.2. Increasing demand for animal-derived food products
4.1.3. Growing demand for Pet insurance and animal health expenditure
4.1.4. Rising livestock population and favourable economic conditions
4.2. Market Restraints & Challenges
4.2.1. Strick regulatory policies
4.2.2. High availability of alternative medicines like prebiotics
4.2.3. Lack of new antibiotics
4.2.4. Stringent Approval Process
4.3. Market Opportunities
4.3.1. Growth in companion animal ownership
4.3.2. Lucrative growth opportunities in emerging economies
CHAPTER 5. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET
– BY PRODUCT
5.1. Tetracyclines
5.2. Penicillin’s
5.3. Sulfonamides
5.4. Macrolides
5.5. Aminoglycosides
5.6. Lincosamides
5.7. Fluoroquinolones
5.8. Cephalosporin’s
5.9. Others
CHAPTER 6. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET
– BY DELIVERY MODE
6.1. Premixes
6.2. Oral Powders
6.3. Injections
6.4. Oral Solutions
6.5. Others
CHAPTER 7. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET
– BY ANIMAL TYPE
7.1. Production Animal
7.1.1. Poultry
7.1.1. Swine
7.1.2. Cattle
7.1.3. Fish
7.1.4. Sheep & Goats
7.2. Companion Animal
7.2.1. Dogs
7.2.2. Cats
7.2.3. Horses
7.2.4. Others
CHAPTER 8. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET
- BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET
- COMPANY PROFILES
9.1. Bayer AG
9.2. Zoetis, Inc.
9.3. Merck &Co., Inc.
9.4. Boehringer Ingelheim GmbH
9.5. Eli Lilly and Company
9.6. Virbac Group
9.7. Ceva Sante Animale
9.8. Vetoquinol S.A.
9.9. IDEXX Laboratories
9.10. Dechra Pharmaceuticals PLC
9.11. CareFusion
CHAPTER 10. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS
MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
